Growth and developmental outcome of infants with in-utero exposure to methadone vs buprenorphine

J Perinatol. 2015 Aug;35(8):656-9. doi: 10.1038/jp.2015.22. Epub 2015 Apr 2.

Abstract

Objective: To compare early growth and developmental outcome of infants with in-utero exposure to low-dose methadone (<100 mg per day), high-dose methadone (⩾100 mg per day) and buprenorphine.

Study design: A retrospective review of infants with in-utero methadone and buprenorphine exposure who were evaluated at the Southcoast Developmental Pediatric clinic in New Bedford, MA, USA was completed. Growth data and developmental testing results during infancy were compared among the groups.

Result: Infants in the high-dose methadone group had lower head circumference z scores and a lower mean score on the Alberta Infant Motor Scale (AIMS). Regression results confirmed an association between methadone dose and head circumference z score and AIMS score.

Conclusion: Exposure to maternal methadone dose in excess of 100 mg is associated with a reduction in infant head circumference when compared with buprenorphine or lower dose methadone, and may have a negative impact on motor skill development during early infancy.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Analgesics, Opioid / adverse effects*
  • Buprenorphine / adverse effects*
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Premature / growth & development*
  • Male
  • Massachusetts
  • Methadone / adverse effects*
  • Mother-Child Relations
  • Neonatal Abstinence Syndrome / diagnosis*
  • Neonatal Abstinence Syndrome / epidemiology
  • Pregnancy
  • Prenatal Exposure Delayed Effects
  • Retrospective Studies
  • Young Adult

Substances

  • Analgesics, Opioid
  • Buprenorphine
  • Methadone